Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 97,052
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12618059 | Anc80 encoding sphingolipid-metabolizing proteins | 🖼🧊📄§ | 2026-05-05 | 2039-03-07 | 0 | 31 |
| 12617825 | Methods and compositions for reducing the immunogenicity of chimeric notch receptors | 🖼🧊📄§ | 2026-05-05 | 2042-04-08 | 0 | 31 |
| 12618024 | Microcell systems for controlled release of fragrances | 🖼🧊📄§ | 2026-05-05 | 2042-12-20 | 0 | 31 |
| 12618044 | Specification of functional cranial placode derivatives from human pluripotent stem cells | 🖼🧊📄§ | 2026-05-05 | 2042-12-21 | 0 | 31 |
| 12617858 | Anti-Müllerian hormone receptor 2 antibodies and methods of use | 🖼🧊📄§ | 2026-05-05 | 2041-01-29 | 0 | 31 |
| 12616646 | Use of rochelle salt | 🖼🧊📄§ | 2026-05-05 | 2041-12-15 | 0 | 31 |
| 12616665 | Neutrophil-to-lymphocyte ratio decreasing agent | 🖼🧊📄§ | 2026-05-05 | 2041-11-12 | 0 | 31 |
| 12617861 | Anti-OX40 antibody and method of treatment | 🖼🧊📄§ | 2026-05-05 | 2041-04-16 | 0 | 31 |
| 12616662 | Lipid particles for nucleic acid delivery and clinical applications of same | 🖼🧊📄§ | 2026-05-05 | 2042-11-17 | 0 | 31 |
| 12617809 | Cardioprotective lipid and method of use | 🖼🧊📄§ | 2026-05-05 | 2042-09-22 | 0 | 31 |
| 12617014 | AU, AG and rich phytochemical payload nanomaterials, antiviral/antibacterial products and synthesis methods | 🖼🧊📄§ | 2026-05-05 | 2042-05-10 | 0 | 31 |
| 12616656 | Adventitial painting modality of local drug delivery to abate intimal hyperplasia | 🖼🧊📄§ | 2026-05-05 | 2042-05-20 | 0 | 31 |
| 12616734 | Chimeric antigen receptor specifically binding to cd 300C antigen or receptor thereof | 🖼🧊📄§ | 2026-05-05 | 2042-05-27 | 0 | 31 |
| 12616723 | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity | 🖼🧊📄§ | 2026-05-05 | 2043-11-13 | 0 | 31 |
| 12616681 | Compositions and methods for treating renal injury | 🖼🧊📄§ | 2026-05-05 | 2042-08-22 | 0 | 31 |
| 12616677 | Injectable pharmaceutical compositions and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-01 | 0 | 31 |
| 12616678 | Methods to of aldehyde dehydrogenases for treatment of cancer | 🖼🧊📄§ | 2026-05-05 | 2041-06-10 | 0 | 31 |
| 12616686 | Donepezil oral films | 🖼🧊📄§ | 2026-05-05 | 2043-07-18 | 0 | 31 |
| 12616689 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | 🖼🧊📄§ | 2026-05-05 | 2043-08-30 | 0 | 31 |
| 12616690 | Specific AKT3 activator and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2044-03-15 | 0 | 31 |
| 12616687 | Treatment of viral infection, disease or disorder using a selective sir agonist | 🖼🧊📄§ | 2026-05-05 | 2042-11-04 | 0 | 31 |
| 12616694 | Pharmaceutical compositions for subcutaneous administration of levosimendan | 🖼🧊📄§ | 2026-05-05 | 2041-12-08 | 0 | 31 |
| 12616700 | Therapeutic regimen | 🖼🧊📄§ | 2026-05-05 | 2043-07-07 | 0 | 31 |
| 12616698 | Methods for reducing liver fat and for treating fatty liver disorders | 🖼🧊📄§ | 2026-05-05 | 2043-11-22 | 0 | 31 |
| 12616697 | Methods of treatment with myosin modulator | 🖼🧊📄§ | 2026-05-05 | 2041-08-26 | 0 | 31 |
| 12616709 | Pharmaceutical composition for treating sepsis and use thereof | 🖼🧊📄§ | 2026-05-05 | 2041-03-23 | 0 | 31 |
| 12616708 | Methods for treating pulmonary non-tuberculous mycobacterial infections | 🖼🧊📄§ | 2026-05-05 | 2044-11-07 | 0 | 31 |
| 12616711 | Therapeutic dendrimer | 🖼🧊📄§ | 2026-05-05 | 2040-09-25 | 0 | 31 |
| 12616710 | Topical compositions | 🖼🧊📄§ | 2026-05-05 | 2045-07-23 | 0 | 31 |
| 12616715 | Nanotherapy targeting RHAMM-positive tumors | 🖼🧊📄§ | 2026-05-05 | 2041-04-23 | 0 | 31 |
| 12616719 | Dispersion solution of complex of cerium oxide nanoparticle with protein, method of scavenging reactive species, and method of producing dispersion solution of complex of cerium oxide nanoparticle with protein | 🖼🧊📄§ | 2026-05-05 | 2040-12-25 | 0 | 31 |
| 12616718 | Photosynthetic cellular substances and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2043-04-24 | 0 | 31 |
| 12616722 | Treatment of immune disorders | 🖼🧊📄§ | 2026-05-05 | 2045-01-17 | 0 | 31 |
| 12616725 | Bifidobacterium breve IDCC 4401 strain and its dead cell ID-BBR4401 having excellent acid tolerance and bile tolerance and prophylactic or therapeutic effect on dyslipidemia | 🖼🧊📄§ | 2026-05-05 | 2042-12-30 | 0 | 31 |
| 12616724 | Pharmaceutical composition for preventing or treating intestinal damage comprising Leuconostoc citreum strain as active ingredient | 🖼🧊📄§ | 2026-05-05 | 2042-02-07 | 0 | 31 |
| 12616731 | Process for enhancing organoleptic properties of natural products and natraceuticals thereof | 🖼🧊📄§ | 2026-05-05 | 2041-09-22 | 0 | 31 |
| 12616728 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | 🖼🧊📄§ | 2026-05-05 | 2043-11-21 | 0 | 31 |
| 12616732 | Peptides for treatment of medical disorders | 🖼🧊📄§ | 2026-05-05 | 2042-07-11 | 0 | 31 |
| 12616729 | Psyllium husk granule, method for producing same, and powdered drink containing psyllium husk granule | 🖼🧊📄§ | 2026-05-05 | 2041-02-08 | 0 | 31 |
| 12616737 | Liquid formulations of amylin analogues | 🖼🧊📄§ | 2026-05-05 | 2043-05-30 | 0 | 31 |
| 12616736 | Method of diagnosis of adrenal insufficiency | 🖼🧊📄§ | 2026-05-05 | 2038-10-24 | 0 | 31 |
| 12616735 | Compositions and methods of controlling expression of thermogenin (UCP-1) in skeletal muscles | 🖼🧊📄§ | 2026-05-05 | 2039-07-03 | 0 | 31 |
| 12616738 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | 🖼🧊📄§ | 2026-05-05 | 2042-11-16 | 0 | 31 |
| 12616739 | GLP-1 prodrugs and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-11-05 | 0 | 31 |
| 12616743 | Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them | 🖼🧊📄§ | 2026-05-05 | 2043-08-16 | 0 | 31 |
| 12616746 | Infectious disease antigens and vaccines | 🖼🧊📄§ | 2026-05-05 | 2042-10-03 | 0 | 31 |
| 12616744 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2043-12-06 | 0 | 31 |
| 12616740 | Methods of using a GIP/GLP1 co-agonist for therapy | 🖼🧊📄§ | 2026-05-05 | 2045-05-23 | 0 | 31 |
| 12616754 | Composition for delivery of a bioactive agent and method of manufacture and use thereof | 🖼🧊📄§ | 2026-05-05 | 2040-07-14 | 0 | 31 |
| 12616753 | HSP70 inhibitors and methods of using same | 🖼🧊📄§ | 2026-05-05 | 2041-03-30 | 0 | 31 |